Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Exacctnt who wrote (1553)	3/10/1999 2:43:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 2539

Bob, it makes sense. <eom>

To: Exacctnt who wrote (1553)	3/10/1999 3:34:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 2539

Excerpts from a Bloomberg update: The new class of DuPont life sciences tracking stock could be expected to trade at higher multiples of estimated future profit than its existing shares, making it more useful as currency to pay for acquisitions and alliances, analysts said. ''It should give them some flexibility, and I expect them to use it for acquisitions'' and positions in other companies, said Bill Fiala, an analyst at Edward Jones who rates the stock a ''strong buy.'' Wilmington, Delaware-based DuPont said it expects to file to sell the tracking stock no sooner than the end of this year, and that the move will then be subject to shareholder approval. news.com